Skip to content
Disclosery

MAK CAPITAL ONE LLC

Follow

13F filer, CIK 1385702, NEW YORK, NY

MAK CAPITAL ONE LLC reported $713,794,826 across 17 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 82.45% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001013594-26-000909

Period
2026-06-30
Reported value
$714M
Holdings
17
Top 10 weight
82.45%
New
1
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
QUREadded+790,846$36.4M
CAInew+1,937,229$34.5M
CLPTadded+474,372$8.46M
ANNXadded+1,138,137$6.5M
GGALadded+56,800$2.84M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SKYreduced-650,000-$57.3M
COURexited-5,618,749-$32.7M
UDMYexited-3,658,520-$16.9M
PLXexited-3,544,139-$7.69M
LODEreduced-573,552-$2.39M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001013594-26-000909, largest first. % of portfolio is the value over $713,794,826, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AGYSAGILYSYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,192,730 shares; 2024Q4: 1,192,730 shares; 2025Q1: 1,192,730 shares; 2025Q2: 1,192,730 shares; 2025Q3: 1,192,730 shares; 2025Q4: 1,192,730 shares; 2026Q1: 1,192,730 shares; 2026Q2: 1,192,730 shares 1,192,730$125M17.46%0Timeline
GGALGRUPO FINANCIERO GALICIA S.AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,343,488 shares; 2026Q1: 1,429,075 shares; 2026Q2: 1,485,875 shares 1,485,875$74.3M10.41%+56,800Timeline
ACHCACADIA HEALTHCARE COMPANY INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,432,962 shares; 2026Q2: 2,432,962 shares 2,432,962$71.8M10.07%0Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 441,205 shares; 2026Q2: 1,232,051 shares 1,232,051$56.7M7.95%+790,846Timeline
SKYCHAMPION HOMES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,500,000 shares; 2024Q4: 2,500,000 shares; 2025Q1: 2,500,000 shares; 2025Q2: 2,500,000 shares; 2025Q3: 2,000,000 shares; 2025Q4: 2,000,000 shares; 2026Q1: 1,282,374 shares; 2026Q2: 632,374 shares 632,374$55.7M7.81%-650,000Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 16,955,098 shares; 2025Q3: 26,017,616 shares; 2025Q4: 30,005,343 shares; 2026Q1: 33,621,487 shares; 2026Q2: 33,621,487 shares 33,621,487$53.8M7.54%0Timeline
CLPTCLEARPOINT NEURO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,901,489 shares; 2026Q2: 2,375,861 shares 2,375,861$42.4M5.94%+474,372Timeline
SUPVGRUPO SUPERVIELLE S.A.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,728,274 shares; 2024Q4: 2,728,274 shares; 2025Q1: 2,728,274 shares; 2025Q2: 2,925,268 shares; 2025Q3: 4,000,000 shares; 2025Q4: 4,000,000 shares; 2026Q1: 4,250,000 shares; 2026Q2: 4,250,000 shares 4,250,000$41.1M5.75%0Timeline
CAICARIS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,937,229 shares 1,937,229$34.5M4.84%newTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,958,527 shares; 2026Q1: 4,724,043 shares; 2026Q2: 5,862,180 shares 5,862,180$33.5M4.69%+1,138,137Timeline
LABSTANDARD BIOTOOLS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,774,721 shares; 2025Q2: 5,597,422 shares; 2025Q3: 15,931,806 shares; 2025Q4: 19,288,158 shares; 2026Q1: 26,172,626 shares; 2026Q2: 28,813,904 shares 28,813,904$23.7M3.32%+2,641,278Timeline
LODECOMSTOCK INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,763,729 shares; 2026Q2: 5,190,177 shares 5,190,177$21.6M3.02%-573,552Timeline
CYRXCRYOPORT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 818,162 shares; 2025Q4: 1,199,225 shares; 2026Q1: 1,423,265 shares; 2026Q2: 1,277,359 shares 1,277,359$20.1M2.81%-145,906Timeline
HNSTHONEST CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,528,704 shares; 2026Q1: 4,776,088 shares; 2026Q2: 4,776,088 shares 4,776,088$17.5M2.45%0Timeline
CVECENOVUS ENERGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 536,832 shares; 2026Q1: 536,832 shares; 2026Q2: 536,832 shares 536,832$16.2M2.27%0Timeline
PESIPERMA-FIX ENVIRONMENTAL SVCSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 92,610 shares; 2025Q3: 815,576 shares; 2025Q4: 918,673 shares; 2026Q1: 918,673 shares; 2026Q2: 1,032,958 shares 1,032,958$14.8M2.07%+114,285Timeline
YTRAYATRA ONLINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 12,170,301 shares; 2024Q4: 12,170,301 shares; 2025Q1: 12,170,301 shares; 2025Q2: 12,170,301 shares; 2025Q3: 12,170,301 shares; 2025Q4: 12,170,301 shares; 2026Q1: 12,170,301 shares; 2026Q2: 12,170,301 shares 12,170,301$11.5M1.61%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SKYCHAMPION HOMES INC1,000,000$74.4Mput
COURCOURSERA INC5,618,749$32.7Mshares
UDMYUDEMY INC3,658,520$16.9Mshares
PLXPROTALIX BIOTHERAPEUTICS INC3,544,139$7.69Mshares
FVRRFIVERR INTL LTD80,479$806Kshares
SGMOSANGAMO THERAPEUTICS INC561,538$139Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001013594-26-000909 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001013594-26-000909 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001013594-26-000603 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001013594-26-000253 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001013594-25-001426 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001013594-25-001034 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001013594-25-000675 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001013594-25-000299 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001013594-24-000971 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001013594-24-000665 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001013594-24-000484 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001013594-24-000206 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001013594-23-000928 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001013594-23-000692 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001013594-23-000489 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001013594-23-000257 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001567619-22-020084 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001567619-22-016272 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001567619-22-011010 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001567619-22-004369 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001567619-21-020483 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001567619-21-015835 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001567619-21-010488 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001567619-21-004015 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001567619-20-019895 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001567619-20-015523 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001567619-20-010437 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001567619-20-004022 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001567619-19-021333 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001567619-19-016730 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR/A 0001567619-19-011504 Quarter ended 2019-03-312019-05-17acceptance time not in the bulk data set
13F-HR 0001567619-19-010972 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001567619-19-004154 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001567619-18-006072 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001567619-18-000964 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001140361-18-023579 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001140361-18-007783 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001140361-17-042348 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001140361-17-031574 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001140361-17-020411 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001140361-17-006681 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0001140361-16-086103 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001140361-16-076470 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0001140361-16-064990 Quarter ended 2016-03-312016-05-13acceptance time not in the bulk data set
13F-HR 0001140361-16-052841 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR 0001140361-15-041403 Quarter ended 2015-09-302015-11-16acceptance time not in the bulk data set
13F-HR 0001140361-15-031979 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0001140361-15-020027 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0001140361-15-006556 Quarter ended 2014-12-312015-02-13acceptance time not in the bulk data set
13F-HR 0001140361-14-042294 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR 0001140361-14-032794 Quarter ended 2014-06-302014-08-14acceptance time not in the bulk data set
13F-HR 0001140361-14-021671 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR 0001140361-14-007939 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set
13F-HR 0001140361-13-042825 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR 0001140361-13-032994 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set